Mnemo Therapeutics
Immunotherapies for cancer treatment.
What is the issue to solve?
Limited availability of cancer-specific targets for immunotherapies and T cell exhaustion.
What’s their solution?
Developing immunotherapies for cancer treatment by discovering new cancer targets and enhancing immune activity and persistence.
Who is their product for?
Cancer researchers, pharmaceutical companies, and oncologists are the main targets.
Competitors
AI Disclaimer
We have generated these company profiles using AI and feeding it the companies website. Because of that we cannot guarantee the accuracy and we welcome any feedback, we will promptly change any inaccuracies.
Thank you!